Your Position:Home>Products>Monoclonals/Polyclonals>Anti-Human ISG15 Recombinant Antibody

Anti-Human ISG15 Recombinant Antibody

  • Cat. No.:RB9THY485043
  • Price:Negotiable
  • Clicks:290

Product Detail

Product Parameters

FormLiquid
Host SpeciesHuman
ClonalityMonoclonal
IsotypeVHH-hFc
Purity>95% as determined by SDS-PAGE.
PurificationProtein A/G purified from cell culture supernatant.
Endotoxin Level<10 EU/mg
ApplicationsELISA, WB, Neutralization
Species ReactivityHomo sapiens (Human)
TargetG1P2, IP17, ISG15, Interferon-induced 15 kDa protein, Interferon-induced 17 kDa protein, UCRP, Ubiquitin cross-reactive protein, Ubiquitin-like protein ISG15, hUCRP
Storage Buffer0.01M PBS pH 7.4
Stability and StorageUse a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
ReconstitutionReconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping ConditionIn general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Product Usage InformationELISA: 1:2000-1:20000
Accession NumberP05161
Background

Ubiquitin-like protein ISG15 is a ~17 kDa protein. Ubiquitin-like protein which plays a key role in the innate immune response to viral infection either via its conjugation to a target protein (ISGylation) or via its action as a free or unconjugated protein. ISGylation involves a cascade of enzymatic reactions involving E1, E2, and E3 enzymes which catalyze the conjugation of ISG15 to a lysine residue in the target protein. Its target proteins include IFIT1, MX1/MxA, PPM1B, UBE2L6, UBA7, CHMP5, CHMP2A, CHMP4B and CHMP6. Isgylation of the viral sensor IFIH1/MDA5 promotes IFIH1/MDA5 oligomerization and triggers activation of innate immunity against a range of viruses, including coronaviruses, flaviviruses and picornaviruses. Can also isgylate: EIF2AK2/PKR which results in its activation, RIGI which inhibits its function in antiviral signaling response, EIF4E2 which enhances its cap structure-binding activity and translation-inhibition activity, UBE2N and UBE2E1 which negatively regulates their activity, IRF3 which inhibits its ubiquitination and degradation and FLNB which prevents its ability to interact with the upstream activators of the JNK cascade thereby inhibiting IFNA-induced JNK signaling.

1. Kim, YJ. et al. (2016) PLoS pathogens 12, e1005850. PMID: 27564865
2. Deng, Z. et al. (2024) Bone research 12, 63. PMID: 39465252
3. Liu, G. et al. (2021) Nature microbiology 6, 467-478. PMID: 33727702
4. Swaim, CD. et al. (2017) Molecular cell 68, 581-590.e5. PMID: 29100055
NoteFor research use only
For Research Use Only. Not for Diagnostic Procedures.

Related Products:
Total 33055 records,Divided into 1653 pages,The 1 pages | First Prev Next Last
Live Chat
  • Tel:
  • WeChat ID: 15898894496
  • Add Message
  • 9:00 AM – 6:00 PM